Back to Search Start Over

Moving the Goalpost Toward Remission: The Case for Combination Immunomodulatory Therapies in Psoriatic Arthritis.

Authors :
Scher, Jose U.
Ogdie, Alexis
Merola, Joseph F.
Ritchlin, Christopher
Source :
Arthritis & Rheumatology; Sep2021, Vol. 73 Issue 9, p1574-1578, 5p
Publication Year :
2021

Abstract

The article discusses developments in the treatment of psoriatic arthritis (PsA), particularly the adoption of combination immunomodulatory therapies. Also cited are the use of tumor necrosis factor inhibitors (TNFi) to identify the signs and symptoms of PsA, rheumatoid arthritis (RA), and psoriasis, and some TNFis like etanercept, adalimumab, and infliximab.

Subjects

Subjects :
THERAPEUTIC use of monoclonal antibodies
PSORIATIC arthritis
DRUG efficacy
COMBINATION drug therapy
TREATMENT effectiveness
IMMUNOLOGICAL adjuvants
DISEASE remission
DRUG administration
DRUG dosage

Details

Language :
English
ISSN :
23265191
Volume :
73
Issue :
9
Database :
Complementary Index
Journal :
Arthritis & Rheumatology
Publication Type :
Academic Journal
Accession number :
152165450
Full Text :
https://doi.org/10.1002/art.41765
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details